144 related articles for article (PubMed ID: 9884829)
1. In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci.
Chow JW; Donabedian SM; Clewell DB; Sahm DF; Zervos MJ
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):141-6. PubMed ID: 9884829
[TBL] [Abstract][Full Text] [Related]
2. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin: a phenotypic assessment of NCCLS guidelines.
Dressel DC; Tornatore-Reuscher MA; Boschman CR; Stosor V; Zembower T; Postelnick MJ; Noskin GA; Peterson LR
Diagn Microbiol Infect Dis; 1999 Nov; 35(3):219-25. PubMed ID: 10626133
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
[TBL] [Abstract][Full Text] [Related]
5. Simple combined agar-strip test for detection of enterococcal susceptibility to ampicillin, moderate- or high-level gentamicin resistance and potential additive activity of ampicillin plus gentamicin.
Traub WH; Leonhard B
Chemotherapy; 1993; 39(2):82-7. PubMed ID: 8458250
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
Kariyama R; Kumon H; Chow L; Zervos MJ; Takata T; Tabata M; Chow JW
J Antimicrob Chemother; 1998 Dec; 42(6):836-8. PubMed ID: 10052913
[No Abstract] [Full Text] [Related]
7. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
[TBL] [Abstract][Full Text] [Related]
8. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
9. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
Noone P
Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
[TBL] [Abstract][Full Text] [Related]
10. Genetic diversity of enterococci harboring the high-level gentamicin resistance gene aac(6')-Ie-aph(2'')-Ia or aph(2'')-Ie in a Japanese hospital.
Watanabe S; Kobayashi N; Quiñones D; Nagashima S; Uehara N; Watanabe N
Microb Drug Resist; 2009 Sep; 15(3):185-94. PubMed ID: 19728776
[TBL] [Abstract][Full Text] [Related]
11. Characterization of high-level aminoglycoside-resistant enterococci in Kuwait hospitals.
Udo EE; Al-Sweih N; John P; Jacob LE; Mohanakrishnan S
Microb Drug Resist; 2004; 10(2):139-45. PubMed ID: 15256029
[TBL] [Abstract][Full Text] [Related]
12. [Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Guirguitzova B; Chankova D; Zozikov B; Minkov N
Ann Urol (Paris); 1998; 32(1):15-9. PubMed ID: 9559070
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
Messick CR; Woodward J; Pendland SL
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
[TBL] [Abstract][Full Text] [Related]
15. High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium.
Torres C; Tenorio C; Lantero M; Gastañares MJ; Baquero F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2427-31. PubMed ID: 8285628
[TBL] [Abstract][Full Text] [Related]
16. Genotypic diversity and epidemiology of high-level gentamicin resistant Enterococcus in a Chinese hospital.
Qu TT; Chen YG; Yu YS; Wei ZQ; Zhou ZH; Li LJ
J Infect; 2006 Feb; 52(2):124-30. PubMed ID: 15904965
[TBL] [Abstract][Full Text] [Related]
17. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
18. Molecular screening of virulence genes in high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium isolated from clinical specimens in Northwest Iran.
Hasani A; Sharifi Y; Ghotaslou R; Naghili B; Hasani A; Aghazadeh M; Milani M; Bazmani A
Indian J Med Microbiol; 2012; 30(2):175-81. PubMed ID: 22664433
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal action of gentamicin against enterococci that are sensitive, or exhibit low- or high-level resistance to gentamicin.
Fasola EL; Moody JA; Shanholtzer CJ; Peterson LR
Diagn Microbiol Infect Dis; 1994 May; 19(1):57-60. PubMed ID: 7956015
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium.
Mekonen ET; Noskin GA; Hacek DM; Peterson LR
Microb Drug Resist; 1995; 1(3):249-53. PubMed ID: 9158783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
